TVTXTravere Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Travere Therapeutics, Inc. against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TVTXThis | $4.6B#5 | — | 203.9x#6 | 9.4x#1 | 110.5%#1 | 92.1%#1 | -12.8%#1 | -113.1%#6 | — | — | — | — |
| MRNA | $92.5B#1 | — | 13.7x#4 | 47.6x#2 | -39.9%#2 | 20.8%#2 | -158.1%#2 | -41.7%#3 | -54.6%#1 | — | 830.5%#1 | — |
| ORKA | $6.7B#3 | — | 6.0x#3 | — | — | -25.9%#3 | — | -9.5%#1 | — | — | 284.9%#2 | — |
| VKTX | $3.4B#6 | — | 5.8x#2 | — | — | -227.1%#6 | — | -61.1%#5 | — | — | -26.0%#4 | — |
| RVMD | $41.9B#2 | — | 16.1x#5 | — | — | -88.5%#4 | — | -43.4%#4 | — | — | 229.1%#3 | — |
| DNTH | $4.7B#4 | — | 4.0x#1 | 2326.4x#3 | -67.3%#3 | -91.1%#5 | -8739.3%#3 | -13.9%#2 | — | — | — | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice